Literature DB >> 9765506

Activation of glycine and glutamate receptors increases intracellular calcium in cells derived from the endocrine pancreas.

C D Weaver1, J G Partridge, T L Yao, J M Moates, M A Magnuson, T A Verdoorn.   

Abstract

We studied calcium signaling in a newly described pancreatic cell line, GK-P3, that expresses functional amino acid neurotransmitter receptors. GK-P3 cells express the first strychnine-sensitive glycine receptors reported in a permanent cell line. In addition, GK-P3 cells express alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors. Both types of amino acid receptors showed electrophysiological and pharmacological behavior similar to their neuronal counterparts. The glycine receptors were permeable to Cl- and blocked by the selective antagonist strychnine. AMPA receptors showed limited permeability to Ca2+, were blocked by 6-cyano-2, 3-dihydroxy-7-nitroquinoxaline, and were potentiated by cyclothiazide. Interestingly, activation of either receptor type increased intracellular Ca2+ measured by digital imaging of Fura-2 fluorescence. These Ca2+ signals were completely blocked by 30 microM La3+, suggesting that the Ca2+ entered the cells largely through voltage-dependent Ca2+ channels. Alterations in the extracellular concentrations of Cl- and/or HCO3- had only marginal effects on glycine-evoked Ca2+ signals. However, increases in intracellular Ca2+ mediated by AMPA receptors were absent when the extracellular Na+ was replaced with an impermeant cation, N-methyl-D-glucamine. We conclude that activation of ligand-gated cation or anion channels depolarize GK-P3 cells sufficiently to activate their voltage-gated Ca2+ channels leading to increases in intracellular Ca2+ concentration. Thus, glycine and glutamate receptors may regulate Ca2+-dependent secretory mechanisms in islet cells by altering the membrane potential of these cells. Our data in GK-P3 cells support the growing weight of evidence for a role of amino acid neurotransmitters in pancreatic islets and introduce strychnine-sensitive glycine receptors as a novel target of amino acid neurotransmitter regulation in islets.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765506

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  Characteristics and functions of {alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors expressed in mouse pancreatic {alpha}-cells.

Authors:  Jung-Hwa Cho; Liangyi Chen; Mean-Hwan Kim; Robert H Chow; Bertil Hille; Duk-Su Koh
Journal:  Endocrinology       Date:  2010-02-26       Impact factor: 4.736

Review 2.  Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.

Authors:  G J Lees
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

Review 3.  Paracrine interactions within islets of Langerhans.

Authors:  Duk-Su Koh; Jung-Hwa Cho; Liangyi Chen
Journal:  J Mol Neurosci       Date:  2012-04-13       Impact factor: 3.444

4.  The neurotransmitters glycine and GABA stimulate glucagon-like peptide-1 release from the GLUTag cell line.

Authors:  A Gameiro; F Reimann; A M Habib; D O'Malley; L Williams; A K Simpson; F M Gribble
Journal:  J Physiol       Date:  2005-10-13       Impact factor: 5.182

Review 5.  Beta-Cell Ion Channels and Their Role in Regulating Insulin Secretion.

Authors:  Benjamin Thompson; Leslie S Satin
Journal:  Compr Physiol       Date:  2021-10-12       Impact factor: 9.090

Review 6.  Chloride transporters and channels in β-cell physiology: revisiting a 40-year-old model.

Authors:  Mauricio Di Fulvio; Lydia Aguilar-Bryan
Journal:  Biochem Soc Trans       Date:  2019-12-20       Impact factor: 5.407

7.  Glutamate (mGluR-5) gene expression in brain regions of streptozotocin induced diabetic rats as a function of age: role in regulation of calcium release from the pancreatic islets in vitro.

Authors:  Savitha Balakrishnan; Peeyush Kumar T; C S Paulose
Journal:  J Biomed Sci       Date:  2009-11-10       Impact factor: 8.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.